The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain

Anesthesia and Analgesia

Volumn 100, Issue 5, 2005, Pages 1406-1410

  Obata, Hideaki ^a,b   Saito, Shigeru ^a   Koizuka, Shiro ^a   Nishikawa, Koichi ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; ISOFLURANE; MAPROTILINE; METHYSERGIDE; MILNACIPRAN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; YOHIMBINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; LUMBAR SPINE; MALE; MOTOR DYSFUNCTION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SPINAL CORD; SPINAL NERVE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SPINAL; MALE; PAIN; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD;

EID: 17744394535     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000149546.97299.A2     Document Type: Article

References (26)

1. McQuay HJ, Tramèr M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
2. Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984;104:277-86.
3. Yokogawa F, Kiuchi Y, Ishikawa Y, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 2002;95:163-8.
4. Hwang AS, Wilcox GL. Anaglesic properties of intrathecally administered heterocyclic antidepressants. Pain 1987;28:343-55.
5. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999;82:149-58.
6. Reddy SVR, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 1980;213:525-33.
7. Yaksh TL, Wilson PR. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 1979;208:446-53.
8. Yaksh TL, Pogrel JW, Lee YW, Chaplan SR. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 1995;272:207-14.
9. 2 agonists in rats with nerve ligation. Pain 2001;90:173-9.
10. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63.
11. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 1994;53:55-63.
12. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-6.
13. Eisenach JC. Muscarinic-mediated analgesia. Life Sci 1999;64:549-54.
14. 2 receptor agonists with acetylcholine in spinal analgesic mechanisms in rats with neuropathic pain. Brain Res 2003;965:114-20.
15. Hurley RW, Banfor P, Hammond DL. Spinal pharmacology of antinociception produced by microinjection of μ or δ opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience 2003;118:789-96.
16. Reynolds IJ, Miller RJ. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br J Pharmacol 1988;95:95-102.
17. Phillis JW, Wu PH. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol 1982;72C:179-87.
18. Isenberg KE, Cicero TJ. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 1984;103:57-63.
19. Hall H, Ögren SO. Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 1981;70:393-407.
20. Eisenach JC, Gebhart GF. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesology 1995;83:1046-54.
21. Kawamata T, Omote K, Kawamata M, Namiki A. Analgesic effect of intrathecal desipremine on carrageenan-induced thermal hyperalgesia in the rat. Br J Anaesth 1999;83:449-52.
22. Wang YX, Bowersox SS, Pettus M, Gao D. Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. J Pharmacol Exp Ther 1999;291:1008-16.
23. Mochizuki D, Tsujita R, Yamada S, et al. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Psychopharmacology 2002;162:323-32.
24. Hamel E, Robert J-P, Young AR, MacKenzie ET. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. J Pharmacol Exp Ther 1989;249:879-89.
25. Sawynok J, Reid A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res 1996;73:63-8.
26. Thomas DR, Nelson DR, Johnson AM. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 1987;93:193-200.